Marketing-authorisation holder · Canada
Astellas Pharma Canada Inc
22 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
22 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
22 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADVAGRAF3 mg · Capsule (Extended-Release) | Tacrolimus | Canada | Marketed | 2010 |
| ADVAGRAF1 mg · Capsule (Extended-Release) | Tacrolimus | Canada | Marketed | 2008 |
| ADVAGRAF5 mg · Capsule (Extended-Release) | Tacrolimus | Canada | Marketed | 2008 |
| ADVAGRAF0.5 mg · Capsule (Extended-Release) | Tacrolimus | Canada | Marketed | 2008 |
| AMBISOME50 mg / vial · Powder For Solution | Amphotericin b | Canada | Marketed | 2000 |
| MYRBETRIQ25 mg · Tablet (Extended-Release) | Mirabegron | Canada | Marketed | 2013 |
| MYRBETRIQ50 mg · Tablet (Extended-Release) | Mirabegron | Canada | Marketed | 2013 |
| PROGRAF5 mg · Capsule | Tacrolimus | Canada | Marketed | 1996 |
| PROGRAF0.5 mg · Capsule | Tacrolimus | Canada | Marketed | 2001 |
| PROGRAF5 mg / ml · Solution | Tacrolimus | Canada | Marketed | 1996 |
| PROGRAF1 mg · Capsule | Tacrolimus | Canada | Marketed | 1996 |
| VEOZAH45 mg · Tablet | Fezolinetant | Canada | Marketed | 2025 |
| VESICARE5 mg · Tablet | Solifenacin | Canada | Marketed | 2006 |
| VESICARE10 mg · Tablet | Solifenacin | Canada | Marketed | 2006 |
| VYLOY300 mg / vial · Powder For Solution | Zolbetuximab | Canada | Marketed | 2026 |
| VYLOY100 mg / vial · Powder For Solution | Zolbetuximab | Canada | Marketed | 2025 |
| XOSPATA40 mg · Tablet | Gilteritinib | Canada | Marketed | 2020 |
| XTANDI40 mg · Capsule | Enzalutamide | Canada | Marketed | 2013 |
| ADENOCARD INJECTION -PRE-FILLED SYRINGE3 mg / ml · Solution | Adenosine | Canada | Cancelled | 1994 |
| ADENOCARD - LIQ RAPID BOLUS IV 3MG/ML3 mg / ml · Solution | Adenosine | Canada | Cancelled | 1996 |
| ADENOSCAN - (FOR IV INFUSION ONLY)3 mg / ml · Solution | Adenosine | Canada | Cancelled | 1995 |
| AMEVIVE15 mg / 0.5 ml · Powder For Solution | Alefacept | Canada | Cancelled | 2004 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 22 | 18 | 4 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.